Bond Baxter International 0.779% ( USU07181BJ56 ) in USD

Baxter International

99.412 % ⇌

United States

USU07181BJ56 ( in USD )

0.779% per year ( payment 2 times a year)

11/29/2024 - Bond has expired

2 000 USD

300 000 000 USD

U07181BJ5

BBB ( Lower medium grade - Investment-grade )

Baxter International is a global healthcare company that develops, manufactures, and markets products for hospitals, healthcare providers, and patients worldwide, focusing on renal care, medication delivery, and critical care.

This financial article provides an overview of the recently matured Baxter International bond, identified by ISIN USU07181BJ56 and CUSIP U07181BJ5. Baxter International, a prominent global medical technology company headquartered in the United States, specializes in a broad range of critical healthcare products for kidney disease, hospital care, and surgical solutions, serving customers worldwide with essential medical devices, pharmaceuticals, and biotechnology products. This particular debt instrument, issued from the United States, bore a fixed interest rate of 0.779%, with interest payments disbursed semi-annually, and was denominated in USD. The total original issuance size for this bond was $300,000,000, with a minimum purchase size set at $2,000. The bond reached its scheduled maturity on November 29, 2024, and has since been successfully repaid to all bondholders, concluding its financial cycle. Prior to its repayment, the instrument was observed trading at a market price of 99.412% of its par value. Standard & Poor's (S&P) had assigned a credit rating of BBB to this bond, reflecting the agency's assessment of the issuer's creditworthiness and the bond's risk profile throughout its term.

Date	Clean price
10/19/2024	99.41%
08/30/2024	99.41%
08/11/2024	99.41%
08/07/2024	100.00%
07/25/2024	99.41%
10/19/2023	99.41%
09/03/2023	99.41%